Akero Therapeutics, Inc. — Director's Dealing 2021

Jun 30, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Akero Therapeutics, Inc. (AKRO)
CIK: 0001744659
Period of Report: 2021-06-21

Reporting Person: Skorpios Trust (10% Owner)
Reporting Person: Blue Horizon Enterprise Ltd (10% Owner)
Reporting Person: Ezbon International Ltd (10% Owner)
Reporting Person: Montrago Trustees Ltd (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4907829	Indirect

Footnotes

F1: Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,346,298 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 2,561,531 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.